This site uses modern web standards that aren't supported by your browser. For best results, please upgrade to Google Chrome, Microsoft Edge, or Mozilla Firefox.

Health Authorities Asia

Health Authorities Asia

Health Authorities in Asia

Resources for understanding Unique Device Identification (UDI) regulatory requirements in Asia including China and South Korea

Introduction to China UDI

The National Medical Products Administration (NMPA) is the regulating body in China for drugs and medical devices.

China NMPA has responsibilities including drafting laws and regulations for drugs, medical devices and cosmetics, as well as establishing medical device standards and classification systems. NMPA has implemented an electronic medical device registration management system and has identified UDI requirements. Although the regulatory process can be challenging due to rapid change, bringing medical devices to market in China is a high-potential future growth area for many US manufacturers.

Download Slides

CURRENT UPDATE: September 30, 2020, China NMPA officially announced a delay to the UDI submission milestone for Batch 1 Medical Devices, from October 1, 2020 to January 1, 2021. The official/public announcement (in Chinese) is hosted here.

Get Started-China NMPA UDI

Let’s talk! Get started on your UDI data submission plan. Contact us today. 


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.